When SSRIs fail: the neuromodulation pathway

Device-based neuromodulation therapies are emerging as an alternative treatment pathway for patients with depression who do not respond adequately to SSRIs. The article examines how neuromodulation devices can address treatment-resistant depression, positioning them as a viable clinical option for this patient population.